Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,501 to 1,520 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential New Treatments for Kawasaki Disease, Its Variations, and Multisystem Inflammatory Syndrome. | SN Compr Clin Med | 2021 | 33786417 | PubTator, text mining | PubMed |
| Expertenkonsensus zu praxisrelevanten Aspekten bei der Behandlung der chronischen Urtikaria. | Allergo J | 2021 | 33785991 | PubTator, text mining | PubMed |
| Proceedings of the Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2020. | Allergy Asthma Clin Immunol | 2021 | 33785055 | PubTator, text mining | PubMed |
| Preoperative immune landscape predisposes adverse outcomes in hepatocellular carcinoma patients with liver transplantation. | NPJ Precis Oncol | 2021 | 33772139 | PubTator, text mining | PubMed |
| Plasma filtration with dialysis for the treatment of capillary leak syndrome occurring secondary to surgery for colon cancer-related perforating peritonitis. | Clin Case Rep | 2021 | 33768874 | PubTator, text mining | PubMed |
| Subcutaneous C1-Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1-INH-HAE. | Clin Case Rep | 2021 | 33768824 | PubTator, text mining | PubMed |
| Molecular Basis for Bordetella pertussis Interference with Complement, Coagulation, Fibrinolytic, and Contact Activation Systems: the Cryo-EM Structure of the Vag8-C1 Inhibitor Complex. | mBio | 2021 | 33758081 | PubTator, text mining | PubMed |
| Omics data integration identifies ELOVL7 and MMD gene regions as novel loci for adalimumab response in patients with Crohn's disease. | Sci Rep | 2021 | 33750834 | PubTator, text mining | PubMed |
| Editorial: The Role of Complement in Microbial Infections. | Front Immunol | 2021 | 33746982 | PubTator, text mining | PubMed |
| Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State. | Front Mol Neurosci | 2021 | 33746710 | PubTator, text mining | PubMed |
| A comprehensive insight into the role of zinc deficiency in the renin-angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients. | Saudi J Biol Sci | 2021 | 33746538 | PubTator, text mining | PubMed |
| The Expanding Spectrum of Mutations in Hereditary Angioedema. | J Allergy Clin Immunol Pract | 2021 | 33746090 | PubTator, text mining | PubMed |
| A Comprehensive Phylogenetic Analysis of the Serpin Superfamily. | Mol Biol Evol | 2021 | 33744972 | PubTator, text mining | PubMed |
| Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn's Disease. | Front Immunol | 2021 | 33737936 | PubTator, text mining | PubMed |
Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study. | Front Immunol | 2021 | 33737935 | PubTator, text mining | PubMed |
| Gene variants of coagulation related proteins that interact with SARS-CoV-2. | PLoS Comput Biol | 2021 | 33730015 | PubTator, text mining | PubMed |
| Shenlian extract protects against ultrafine particulate matter-aggravated myocardial ischemic injury by inhibiting inflammation response via the activation of NLRP3 inflammasomes. | Environ Toxicol | 2021 | 33729688 | PubTator, text mining | PubMed |
| MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19. | Genet Mol Biol | 2021 | 33729332 | PubTator, text mining | PubMed |
| PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma. | Medicine (Baltimore) | 2021 | 33725976 | PubTator, text mining | PubMed |
| Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema? | Clin Rev Allergy Immunol | 2021 | 33725263 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=76